← Leaderboards
Jerel Adam Fields
University Of California, San Diego
$5,886,313
Attributed
$9,000,744
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,000,744 · 9
By mechanism
R01$7,184,512 · 4
R56$748,603 · 1
K01$479,668 · 1
R41$466,421 · 1
F32$93,763 · 1
F31$27,777 · 1
Top collaborators
- Jennifer E Iudicello3 shared
- Maria Cecilia Garibaldi Marcondes3 shared
- Antoine Chaillon1 shared
- Andrew Mizisin1 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- David J Moore$20,232,553
- Ronald J. Ellis$34,493,757
- Stephen A Spector$131,199,154
- David A Smith$619,381
- Scott L Letendre$25,948,231
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsAlzheimer&AposAffectBrainNeuronsIn VitroPersonsMitochondriaAntiretroviral TherapyHiv InfectionsNeurotoxicityInflammatoryChronicHomeostasisMicrogliaBrain TissueGene ExpressionMonocyteMitochondrial DysfunctionExposure ToHiv Envelope Protein Gp120AutopsyCellsCytokine
Grant awards (18)
Cannabis and Pathogenic Mechanisms influencing Blood Brain Barrier Function in HIV$1,244,206
R01 · FY2025 · DA
Disentangling the HIV/opioid intertwined mechanisms on mitochondrial mediated inflammasome activation, neurotoxicity and targeting strategies: In vivo and in vitro analyses of fresh human brain$794,203
R01 · FY2025 · DA
The role of TREM2 in Alzheimer's disease related neuropathogenesis in people with HIV$768,131
R01 · FY2025 · AG · contact PI
The role of TFAM alterations in HIV- and ART-induced mitochondrial dysfunction in the brain$395,000
R01 · FY2025 · MH · contact PI
Cannabis and Pathogenic Mechanisms influencing Blood Brain Barrier Function in HIV$1,239,289
R01 · FY2024 · DA
The role of TFAM alterations in HIV- and ART-induced mitochondrial dysfunction in the brain$395,000
R01 · FY2024 · MH · contact PI
Cannabis and Pathogenic Mechanisms influencing Blood Brain Barrier Function in HIV$1,242,683
R01 · FY2023 · DA
The role of TFAM alterations in HIV- and ART-induced mitochondrial dysfunction in the brain$395,000
R01 · FY2023 · MH · contact PI
Astoglial reactivity and metabolism in aging people with HIV$316,000
R01 · FY2023 · MH · contact PI
The role of TFAM alterations in HIV- and ART-induced mitochondrial dysfunction in the brain$395,000
R01 · FY2022 · MH · contact PI
The role of TREM2 in Alzheimer's disease neuropathogenesis in HIV+ individuals$748,603
R56 · FY2020 · AG · contact PI
Mitochondrial biogenesis dysfunction in the CNS of HIV-infected individuals on antiretroviral therapy$159,704
K01 · FY2020 · MH · contact PI
Mitochondrial biogenesis dysfunction in the CNS of HIV-infected individuals on antiretroviral therapy$175,122
K01 · FY2019 · MH · contact PI
Mitochondrial biogenesis dysfunction in the CNS of HIV-infected individuals on antiretroviral therapy$144,842
K01 · FY2018 · MH · contact PI
Development of Pirenzepine for HIV-SN$466,421
R41 · FY2017 · NS
Mechanisms of mitochondrial fission/fusion dysregulation during HIV-1-associated$44,549
F32 · FY2014 · NS · contact PI
Mechanisms of mitochondrial fission/fusion dysregulation during HIV-1-associated$49,214
F32 · FY2013 · NS · contact PI
Regulation of Astrocyte TIMP-1 in HIV-Associated Dementia$27,777
F31 · FY2011 · NS · contact PI